Published

Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of experimental pharmacology
Date: 2020-01-01
Source: PubMed
DOI: 10.2147/jep.s255375
PubMed: 33447096

Authors

Grassi G Cecchelli C Vignozzi L Pacini S

Watch author

Derived topics and classifications

psilocybin OCD Review Article Inflammation Immune Function Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.2020-01-01

Related papers

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Mechanistic Studies of Psilocybin in Headache DisordersClinicalTrials.gov · 2026-07-13 Repeat Dosing of Psilocybin in Headache DisordersClinicalTrials.gov · 2024-02-09 Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study IIClinicalTrials.gov · 2023-10-12 NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.ClinicalTrials.gov · 2022-11-16 Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.The Cochrane database of systematic reviews · 2024-09-12 Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine) · 2020-01-01